Scientific Programme

EPA leadership and congress organisers are working together to build an exciting congress programme with an adapted format mindful of the current context. Sign up for the congress newsletter to receive the latest updates about EPA 2021, including scientific programme announcements, registration opening, e-poster information, deadline reminders, and more.

Confirmed Sessions

Click on the session names to view more information.

Plenary Sessions

Empathy and Embodied Self: Neural Underpinnings of Interpersonal Relations

Session Chair: Peter Falkai, Germany
Speaker: Vittorio Gallese, Italy

Stability and Change: Mental Disorders Across Lifetime

Session Chair: Philip Gorwood, France
Speaker: Avshalom Caspi, USA


Should Schizoaffective Disorder be Diagnosed Cross-Sectionally (ICD-11) instead of Longitudinally (DSM-5)?

Session Chair: Silvana Galderisi, Italy

Speaker: Peter Falkai, Germany

Speaker: Ingrid Melle, Norway

The COVID-19 Pandemic: Is it a Turning Point for e-Health?

Session Chair: Judit Simon, Austria

Speaker: Heleen Riper, The Netherlands

Speaker: Hans-Jürgen Möller, Germany

State of the Art Sessions

Personalised Psychiatry and Predictive Modelling: Translational Gimmick or Realistic Way Forward?

Session Chair: Julian Beezhold, UK
Speaker: Nikolaos Koutsouleris, Germany

The Clinical Characterisation of the Patient with Primary Psychosis Aimed at Personalisation of Management

Session Chair: Andrea Raballo, Italy
Speaker: Mario Maj, Italy

Digital Interventions in Severe Mental Disorders

Session Chair: Geert Dom, Belgium
Speaker: Sandra Bucci, UK

Targets and Outcomes of Psychotherapies for Mental Disorders

Session Chair: Cécile Hanon, France
Speaker: Pim Cuijpers, The Netherlands

Digital-based Parent Training (DPT) Programmes for Parents of Children with Disruptive Behaviours

Session Chair: Mario Maj, Italy
Speaker: Christoph Correll, Germany


Implementing Digital Mental Health Across Europe

Session Chairs:
Wolfgang Gaebel, Germany
Hilkka Kärkkäinen, Finland

Managing the Challenges in Implementing Digital Mental Health in Europe
Speaker: Oyono Vlijter, The Netherlands

The EPA-Council of National Associations in Implementing Digital Mental Health Across Europe: Opportunities and Challenges
Speaker: Simavi Vahip, Turkey

The Role of Research in Evaluating and Implementing Digital Mental Health
Speaker: Heleen Riper, The Netherlands

The Integrative Function of a Transnational Policy and Roadmap for Action Planning in Implementing Digital Mental Health
Speaker: Wolfgang Gaebel, Germany

Consequences of COVID-19 Outbreak on Mental Health

Session Chairs:
Stephanie Le Hellard, Norway
Simavi Vahip, Turkey

Lessons Learned From the Coronavirus Health Crisis in Spain
Speaker: Celso Arango, Spain

Lessons Learned From the Coronavirus Health Crisis in the Nordic Countries
Speaker: Unnur Valdimarsdottir, Iceland

Evidence-Based Family Interventions in Perinatal Psychiatry

Session Chairs:
Tamas Kurimay, Hungary
Martina Rojnic-Kuzman, Croatia

Development and Efficacy of a Psychoeducational Family Intervention for Perinatal Depression
Speaker: Andrea Fiorillo, Italy

Perinatal Psychiatry and Families’ Mental Health: Evidences from some French Graduated and Integrated Practices
Speaker: Anne-Laure Sutter-Dallay, France

What Is the Role of Video Feedback in Supporting Parents Experiencing Mental Health Problems?
Speaker: Jane Barlow, UK

Family Healing: Contextual Interventions in Perinatal Clinical Practice
Speaker: Tamas Kurimay, Hungary

Implementing Alternatives to Coercion in Mental Health Care

Session Chairs:
Meryam Schouler-Ocak, Germany

The WPA Programme on Implementing Alternatives to Coercion
Speaker: Helen Herrman, Australia

Involuntary Detention and Treatment: Are We Edging Toward a Paradigm Shift?
Speaker: Sonia Johnson, UK

Service User Perspectives on Coercion in Mental Health
Speaker: Hilkka Kärkkäinen, Finland

Implementing the Quality Rights Programme in Public Mental Health
Speaker: Soumitra Pathare, India

Epigenetics in Mental Disorders

Session Chairs:
Philip Gorwood, France
Jan Wise, UK

How DNA Methylation at Birth Can Inform on Risk for Mental Disorders Later
Speaker: TBA

Epigenetic studies in Adult ADHD
Speaker: Tetyana Zayats, USA

Epigenetic Association with Environmental Risk Factors for Mental Disorders
Speaker: Stephanie Le Hellard, Norway

Epigenetic Pathways in PTSD
Speaker: Tortsen Klengel, USA

Network Analysis for Personalisation of Treatment: Understanding Links Among Symptoms, Risk Factors and Functioning

Session Chairs:
Peter Falkai, Germany
Diego Palao Vidal, Spain

Recovery in Schizophrenia: A Network Analysis of Inter-Relationships Among Disease-Related Variables, Personal Resources, Context-Related Factors and Real-Life Functioning
Speaker: Silvana Galderisi, Italy

Symptom-Specific Assessment of Treatment Efficacy: The Potential of Network Estimation Techniques
Speaker: Lynn Borschloo, The Netherlands

Network Meta-Analysis of Antidepressant Efficacy: Perspective and Challenges for Personalisation of Care
Speaker: Andrea Cipriani, Italy

Network Analyses of Big Data in an Eating Disorder Forum: Relevance to the Understanding of Links Among Symptoms and Risk Factors
Speaker: TBA

Joint Sessions

COVID-19 Pandemic and Psychiatry: Challenges, Experiences and Future Perspectives from Different European Countries

NPA Symposium

Session Chairs:
Simavi Vahip, Turkey
Jerzy Samochowiec, Poland

What Happened to our Patients and Mental Health Services and How Should we be More Ready in the Future?
Speaker: TBA

The Role of Professional’s Associations Under Extraordinary Situations: Contingency, Capacity, and Collaboration
Speaker: TBA

Ethical Issues under the Pressure of a Pandemic
Speaker: Bernardo Carpiniello, Italy

Experiences and Projections for the Future of Research, Training and Other Academic Activities: Will it be the Same?
Speaker: Pavel Mohr, Czech Republic

Session Descriptions

The EPA 2021 scientific programme will cover the latest developments in psychiatry, through state-of-the-art presentations, live moderation, discussions and more. Click below to view detailed descriptions of all the session formats on offer at the EPA Congress.

The European Congress of Psychiatry serves the educational mission of the EPA by providing high-quality courses, covering all aspects of psychiatry. Fees are charged separately for the courses, seats are sold on a first-come, first-served basis as space is limited. Each onsite EPA Course is composed of two 90-minute sessions. EPA Courses held virtually may have different fees, participant limits, and durations.

epa2017 florence courses-9

The State-of-the-Art lectures have a strong clinical focus, providing a complete update on significant aspects of current clinical treatments in European psychiatry. The State-of-the-Art lectures are delivered by top European or worldwide experts and last 45 minutes.


The Plenary lectures are mainly theoretical and research-oriented, with a strong scientific focus. These lectures are delivered by leading psychiatrists, scientists and other mental health professionals invited by the Scientific Programme Committee. They cover the major topics of the congress theme.


Debates offer a lively and fruitful discussion on controversial issues. A chairperson moderates the debate and the following discussion, while two speakers (proponent /opponent) offer and challenge opinions on “hot topics” for 30 minutes each. Participants may also be asked to interact by voting at the beginning and/or end of the session.


These 90-minute sessions focus on specific topics in psychiatry, representing several points of view. Each symposium includes four presentations by international speakers and offers an opportunity for discussion at the end.

Close-up of people communicating while sitting in circle and gesturing

The Workshops are devoted to a specific topic and bring together experts in a given field for intensive discussion. These 90-minute working sessions include at least 30 minutes devoted to discussion and interactivity.


The EPA invites recent graduates to follow its specialist programme, which is tailored to the needs and interests of early career psychiatrists. The ECP programme is composed of a networking evening and a special track of sessions throughout the congress.


Ask the Experts sessions allow participants to meet in a small group with outstanding researchers and clinicians. The format is designed to facilitate informal discussions, allowing participants to present their questions and gain new perspectives. Sessions take place at round tables and are limited to a certain number of participants with advanced sign-up required.


Authors are invited to submit abstracts, classified by topic, up to the indicated limit of submissions per author. Submitted abstracts are reviewed by the Local Organising Committee and scheduled as Oral Communications Sessions, e-Poster Presentations, or e-Poster Viewing.

Those abstracts scoring the highest will be allotted to an Oral Communication Session in which the author will have 8-10 minutes to present the research in the presence of colleagues with related research.

Meeting, Seminar, Working, Teamwork, Planning, Presentation - Speech

Authors in the second-highest category of scoring are invited to present their research findings or important ongoing research as an e-Poster Presentation, where they have 2-3 minutes to present their e-Posters (in front of the e-Poster station) in the presence of a chairperson and colleagues with related research.


All other authors accepted for e-Poster status will be able to view their poster at one of 15-17 e-Poster stations located around the congress centre. The stations are accessible to all delegates throughout the congress for individual viewing. All accepted posters whose authors attended the congress are published in the European Psychiatry Digital Abstract Supplement during and following the congress.


Satellite Symposia are organised by pharmaceutical companies in consultation with the Scientific Programme Committee. These sessions are fully integrated into the congress, but are sessions entirely designed, produced and driven by the pharmaceutical industries by an unrestricted educational grant.